AI assistant
Sending…
AMGEN INC — Director's Dealing 2020
Jan 2, 2020
29819_dirs_2020-01-02_34cd5be2-1592-4ba3-8b13-a94884008089.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BeiGene, Ltd. (BGNE)
CIK: 0001651308
Period of Report: 2020-01-02
Reporting Person: AMGEN INC (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares | 206635013 | Direct |
Footnotes
F1: Reported securities are represented by American Depositary Shares, each of which represents 13 Ordinary Shares of the Issuer.
More from AMGEN INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 19
Interim / Quarterly Report
2026
May 1
Regulatory Filings
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 22
Proxy Solicitation & Information Statement
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7